The earthworm fibrinolytic enzyme-3 (EFE-3, GenBank accession No: AY438622), from the earthworm Eisenia foetida, is a component of earthworm fibrinolytic enzymes. In this study, cDNA encoding the EFE-3 was cloned by RT-PCR. The cDNA contained an open reading frame of 741 nucleotides, which encoded a deduced protein of 247 amino acid residues, including signal sequences. EFE-3 showed a high degree of homology to earthworm (Lumbricus rebullus) proteases F-III-1, F-III-2, and bovine trypsin. The recombinant EFE-3 was expressed in E. coli as inclusion bodies, and the gene encoding the native form of EFE-3 was expressed in COS-7 cells in the medium. Both the refolding product of inclusion bodies and the secreted protease could dissolve the artificial fibrin plate.
Earthworm fibrinolytic enzyme (EFE), a multi-component protease purified from some earthworm breeds, belongs to serine protease family with fibrinolytic activity [1] . It has been used in prevention and treatment of cardiac and cerebrovascular diseases in China for many years [2] . Previous studies focused mainly on the purification, physical/chemical properties, and clinical application of earthworm fibrinolytic enzyme isolated from Lumbicus rubellus, Eisenia foetida or Lumburcus bimastus [3] [4] [5] [6] [7] . Most EFEs showed characteristics of high stability and strong tolerance to organic solvents and high temperature. Chemical modification of these enzymes has been performed for parenteral administration [6, 8] . Comprehensive clinical trials have also been done. The intestinal absorption mechanism of EFE has been clarified by Fan et al. [2] . The study of expression of EFE has also been performed and the fibrinolytic activity of the expression protein was demonstrated [9] .
In this paper, we presented the molecular cloning and sequencing of EFE3, one of EFEs from Eisenia foetida, and its prokaryotic expression in E. coli BL21 (DE3) and eukaryotic expressions in COS-7 cells. This work may lay a foundation for bioengineering of EFEs.
Materials and Methods

Materials
Earthworm, Eisenia foetida, was raised as described by Nakajima et al. [5] .
RNA isolation and cDNA synthesis
Total RNA from the mature earthworm tissue was prepared with TRIzol reagent (Gibco-BRL). Aliquots (2 µg) of total RNA were reverse transcribed to cDNA by using oligo (dT) 16 primers and MMLV (moloney murine leukemia virus) reverse transcriptase (Promega, USA). The generated cDNA was used as the template for PCR.
Polymerase chain reaction (PCR) amplification
PCR was performed with 2 µl cDNA template, 0.5 µl Taq DNA polymerase, and 20 pM of each primer in a 50 µl reaction mixture for 30 cycles in a minicycler. Each cycle was held at 97 °C for 30 s, 48 °C for 60 s, and 72 °C for 60 s. The oligo-nucleotide primers were designed based on the sequences of U25643 and U25648 (GenBank accession number); sense primer: 5'-CGGAATTCAAT-GATTGTCGGA ATTGAAG-3'; antisense primer: 5'-CC-ATGCTTCTAGTTGTTGGTAATAATGTCT-3' (synthe-
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sized by Sangon, China).
Gene cloning
PCR products were subcloned into a pUCm-T vector (Sangon). The recombinants were determined by restriction enzyme analysis and sequencing (Sangon) [10] .
Sequence analysis
The ORF prediction and translation of nucleotide sequence into amino acid sequence were performed with Finder program (NCBI) and Primer 5 program respectively. Homology search and alignment of DNA with protein sequences were done by using the BLAST program [11, 12] .
Construction of the prokaryotic expression plasmid
cDNA encoding the mature form of EFE-3 was amplified by using pUC-EFE-3 as the template by PCR. The sense primer, 5'-CGGAATTCCTAGTTGTTGGTAA-TAATGTCT-3' contained an EcoRI site at 5' end; and the antisense primer, 5'-CCAAGCTTATGTTACTTCTCGC-CCTTGC-3' (Sangon) contained a HindIII site and a stop codon. The PCR product and pET22b(+) vector (Novagen) were digested with EcoRI and HindIII. After purification, the two fragments were ligated with T4 DNA ligase (NEB). Finally, The recombinant of pET-EFE-3 was confirmed by sequencing.
Expression of pET-EFE-3 in E. coli and refolding of the inclusion bodies E. coli strain BL21(DE3) was transformed with pET-EFE. The transformants BL21(DE3)/pET-EFE-3 were grown in 1 liter LB medium plus ampicillin (50 µg/ml) at 37 °C to an A 600 of 0.6. Then, IPTG was added to a final concentration of 1mM to induce the synthesis of the recombinant protein [10] . After 3 h, cells were harvested by centrifugation at 10,000 g at 4 °C. The pellet was resuspended thoroughly in 0.1 culture volume wash buffer (20 mM Tris-HCl, pH 7.5, 10 mM EDTA, 1% Triton X-100). Cells were lysed by sonication on ice, and the lysate was centrifuged at 10,000 g for 10 min at 4 °C; repeated above process twice and saved the pellet. After that, the inclusion bodies were resuspended in solubilization buffer (50 mM CAPS, pH 11.0, 0.3% N-lauroylsarcosine, 0.1 mM DTT) at three different concentrations of 10 mg/ml, 1.0 mg/ml, and 0.5 mg/ml, respectively. Subsequently, Dialysis was performed with dialysis buffer (20 mM TrisHCl, pH 8.5, 0.1 mM DTT) at 4 °C for 8 h, which was over 50 times volume than that of the sample. Repeated the step once. Changed dialysis buffer with DTT-free one, and continued dialysis for 3 h at 4°C, repeated twice. At last, refolding buffer, containing 1 mM reduced glutathione and 0.2 mM oxidized glutathione in dialysis buffer without DTT, was used to protein refolding. The solution was incubated overnight at 4 °C. After dialysis at 37 °C; target protein was concentrated by polyethylene glycol 20000 [13, 14] .
Construction of the eukaryotic expression plasmid
The EFE-3 coding region of the cDNA (including signal sequence) was amplified by PCR. Sense primer: 5'-CAAGCTTATTACTTCTCGCCCT TGC-3', containing an NotI site; antisense primer, 5'-GGAATTCCTAGT-TGTT GGTAATAATGCT-3', containing an EcoRI site and a stop codon. Both the PCR product and pcDNA3.1 (+) vector (Invitrogen) were digested by NotI and EcoRI. After purification and ligation, it subsequently transformed into the JM109 cells for the purpose of selecting the correct insertion. The recombinant of pcDNA-EFE-3 was confirmed by restriction enzyme analysis and sequencing.
Expression of pcDNA-EFE-3 in COS-7 cells
2×10
5 exponentially growing COS-7 cells were inoculated in a 35-mm Nunc plates and cultured for 24 h. Transfection mixture, containing 100 µl sterile, serum-free and antibiotic-free DMEM, 12 µl GeneJammer transfection reagent and 2 µg pcDNA-EFE-3, was prepared. The old medium was removed and 900 µl fresh serum-containing medium was added. The transfection mixture was added dropwisely to the Nunc plate and distributed evenly by gently rocking. Then incubated cells at 37 °C with 5% CO 2 in a humidified incubator for 3 h. Subsequently, added 1 ml RPMI-1640 (Hyclone) medium containing 10% fetal bovine serum to incubate for a further 72 h for transient express EFE-3. Collected the culture medium at 24 h, 36 h, and 48 h after transfection, respectively [15, 16] .
Protein and fibrinolytic activity assays
The protein was analyzed by SDS-PAGE, and the fibrinolytic activity was measured with standard fibrin plates by the method described previously [17] . 20 µl of protein solution was spotted onto the fibrin plates and incubated at 37 °C for 3 h. The protein concentration was measured by using Bradford method [18] with crystalline bovine serum albumin as standards.
Results
Cloning of the cDNA encoding EFE-3
After isolation from earthworm Eisenia foetida, the quality of total RNA checked by agarose gel electrophoresis containing formaldehyde and quantitated the ratio of A 260 /A 280 , was found to be good. The target gene was amplified from the cDNA by PCR. After subcloning the fragments and analyzing the nucleotide sequence of the clones, one cDNA fragment was obtained. The nucleotide sequence and the deduced amino acid sequence of the target gene were presented in Fig. 1 .
Bioinformatics analysis
The cDNA of Eisenia foetida EFE-3 we got contained 859 nucleotides, with an open reading frame starting from position 112 to 853, encoding a polypeptide of 247 amino acid residues.
DNA sequence similarity searching against GenBank by using BLAST program revealed that the EFE-3 cDNA has significant identity to earthworm fibrinolytic enzyme F-III-1 (AB045720, 93%; AF433650, 98%; AF304199, 98%; and U25643, 99%) [9] . The identity between the deduced amino acid sequence of EFE-3 with F-III-1 is 89% (shown in Fig. 2 ; while those different residues are located out of important function sites (shadow indicated the difference in Fig. 2 ). According to Sugimoto et al. [9] and our analysis, the EFE-3 cDNA encodes a preproenzyme that included an N-terminal signal peptide, MELPPGTK, with a cluster of hydrophobic residues, followed by an active form. The native Fig. 1 Nucleotide and deduced amino acid sequences of cDNA encoding EFE-3
The nucleotide and the amino acids are numbered from the 5' end of the cDNA and from the start codon ATG of the preproenzyme, respectively. The stop codon is indicated by a underline.
Fig. 2 Amino acid sequence alignment of the EFE-3 and F-III-1 [9]
The similarity of amino acid sequences between the EFE-3 and F-III-1 is 89%. Gaps, indicated by a dash, are introduced in the sequences to maximize the homology. The amino acid residues of the catalytic triad and the primary substrate specificity determinant sites are boxed. The shadows show the difference of amino acid residues between the EFE-3 and F-III-1. mature EFE-3 comprised of 239 amino acid residues. Homology searching of the deduced amino acid sequence of EFE-3 against the protein entries available at the GenBank; and SWISS-PROT also revealed that the EFE-3 had considerable similarities with mammalian serine proteases such as bovine trypsin, bovine chymotrypsin, etc. (data not shown), indicating the active sites of the trypsins are conserved in the earthworm fibrinolytic proteases. Our results are consistent with that of Sugimoto [9] .
Prokaryotic expression of EFE-3
The native form of EFE-3 amplified by PCR was fused with the pel signal peptide sequence, which is beneficial to the expression of EFE-3 cDNA. The fusion EFE-3 protein was expressed in BL21 (DE3). Fig. 3 showed that the expression of EFE-3 protein was time-dependent after induction by IPTG. A maximal yield of fusion EFE-3 was attained at 5 h after IPTG induction. A relatively pure protein was readily obtained by simple washing with 2% Triton X-100. The mobility of EFE-3 fusion protein was determined by SDS-polyacrylamide gel electrophoresis. The result showed the molecular weight of EFE-3 fusion protein was about 30 kD. mide gel electrophoresis of the harvested medium showed the molecular weight of EFE-3 protein was less than 30 kD (Fig. 4) .
Fig. 3 SDS-PAGE of the BL21 (DE3) harboring the pET-EFE-3
M, molecular mass marker; 1, BL21 (DE3) harboring pET22b(+); 2-4, BL21 (DE3) harboring recombinant pET-EFE-3 after IPTG induction for 3, 5, 7 h respectively. Arrow indicated the expressed EFE-3.
Eukaryotic expression of EFE-3
The complete form of EFE-3 cDNA containing the signal peptide sequence was cloned into the eukaryotic expression vector pcDNA3.1(+), then, the recombinant vector was transfected into COS7 cells. SDS-polyacryla- Expression of recombinant pcDNA-EFE-3 in COS-7 cells M, molecular marker; 1, COS-7 cells harboring pcDNA3.1(+); 2, COS-7 cells harboring recombinant pcDNA-EFE-3 at 24 h after transfection. Arrow indicated the expressed EFE-3.
Activity assay of EFE-3
The lytic activities of the refolded fusion EFE-3 protein and the culture medium of COS-7 cells were assayed by fibrin plates, which were incubated at 37 °C for 3 h. 
Discussion
Although we designed primers based on the sequence of Lumbricus rubellus's F-III-1, there were difference between the sequence of PCR product and F-III-1, indicating genetic diversity existed between different earthworm breeds (Eisenia foetida and Lumbricus rubellus).
EFE-3, fused with a pel signal sequence at N-terminal, was expressed in prokaryotic system. The presence of the pel didn't direct the EFE-3 to the periplasm. The fusion protein was expressed as inclusion bodies. Fusion protein EFE-3 gained activity after refolding, suggesting pel didn't affect the refolding and function of the EFE-3. Lytic activity of COS-7 medium increased from 24 h to 48 h, but disappeared at 72 h. The increasing concentration of protease in the transient expression system before 48 h contributed to the detected increasing lytic activity. After 48 h, COS-7 cells started dying, which resulted in the disappearance of lytic activity at 72 h after transfection.
Earthworm fibrinolytic enzymes were considered as one of the important dissolution tools against both cardiac and cerebrovascular clotting disease [2] . To date, there were more than ten fibrinolytic enzymes genes purified from earthworm, but it was only one report about expressing recombinant EFEs [9] .
The most remarkable feature of fibrinolytic enzymes was its way of absorption, the EFE-3 could be transported into blood through intestinal epithelium and exerted its biological function in circulation [2] . Our study also evidenced this viewpoint (data not shown). Other fibrinolytic enzymes such as urokinase and tissue plasminogen activator could only be used by intraperitoneal injection rather than oral administration. The differences provide interesting clues Function assay of EFE-3
(A) 20 µl of the refolding lumbrokinase from the transformed BL21(DE3) was spotted onto the fibrin plate and incubated at 37 °C for 3 h. 1-3, The starting concentrations of inclusion bodies were 10 mg/ml, 1 mg/ml, 0.5 mg/ml, respectively. (B) The culture medium containings secreated EFE-3 from COS-7 cells transfected with pcDNA-EFE-3 was spotted onto the fibrin plate and incubated at 37 °C for 24 h. 1-3, the culture medium harvested at 24 h, 48 h and 72 h after transfection. N, COS-7 cells without pcDNA-EFE-3 transfection. for clarifying the relationship between the protein action mode and its structure. Success in expressing active EFE-3 protein in prokaryotic cells suggested the EFE could be produced by bioengineering method. The eukaryotic expression of EFE-3 provided a forceful evidence for the application of EFE bioengineering products. However, it is still necessary to characterize the differences between the prokaryotic product and the eukaryotic one.
